News
The company told Newsweek that it remains on track to complete the 500 planned store closures by the end of the fiscal year.
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on ...
Walgreens has agreed to be taken private, but the agreement is a bit complex. There's a reason to buy the stock despite the ...
Cencora, Inc. earns a Buy rating with a $337 fair value. Learn how its specialty drug focus and strategic investments drive ...
NeueHealth, Inc. reports Q2 2025 profitability with $19M adjusted EBITDA, 45% consumer growth, new partnerships, and the innovative NeuePulse platform.
Below are the transcripts from the Q2 earnings call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a ...
ASX:WAG 1 Year Share Price vs Fair Value Explore Australian Wealth Advisors Group's Fair Values from the Community ...
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...
Pool products retailer Leslie’s (NASDAQ:LESL) will be reporting results this Wednesday after market close. Here’s what to ...
A CBS News review of three of DOGE's largest cuts claimed so far found actual savings of 3% of what was claimed.
Where will Palantir stock be in 5 years? Analyze trends, predictions, and market factors to see the potential future of PLTR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results